Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of S-309309 in Healthy and Obese Adults
NCT05247970Phase 1Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jan 2022
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of S-309309 in obesity (3 arms), sponsored by Shionogi & Co., Ltd. Primary endpoint: Number of Participants with Treatment Emergent Adverse Events. Started Jan 2022; status: completed.
02
Drugs
S-309309
03
Conditions
obesity
Beyond the preview
Go deeper on NCT05247970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05247970.